Potential of Stem Cell-Based Therapy for Ischemic Stroke
Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells...
Main Authors: | Hany E. Marei, A. Hasan, R. Rizzi, A. Althani, N. Afifi, C. Cenciarelli, Thomas Caceci, Ashfaq Shuaib |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2018.00034/full |
Similar Items
-
The Role of Stem Cells in the Treatment of Cardiovascular Diseases
by: Estera Bakinowska, et al.
Published: (2024-03-01) -
Stem Cell- and Cell-Based Therapies for Ischemic Stroke
by: Delia Carmen Nistor-Cseppentö, et al.
Published: (2022-11-01) -
Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015) -
The Immunomodulatory Capacity of Induced Pluripotent Stem Cells in the Post-stroke Environment
by: Samantha E. Spellicy, et al.
Published: (2021-03-01) -
Mesenchymal stem cells in the treatment of ischemic stroke
by: Daria D. Namestnikova, et al.
Published: (2024-01-01)